Latest Diabetes: Type II news
Semaglutide Offers Cardiovascular Edge Over Empagliflozin in Type 2 Diabetes
posted June 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
DASH Diet for Diabetes With Low Sodium Reduces BP in Those With Diabetes
posted June 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Finerenone + Empagliflozin Offers Greater Benefit in CKD, T2DM
posted June 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Concurrent Hypertension + Type 2 Diabetes Predict High Mortality Risk
posted June 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Weight-Loss Surgery Produces Lasting Diabetes Remission .jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
Isometric Exercise Training Three Times a Week Preserves Cardiovascular Benefits 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria Related Articles
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD Monthly Specialist Briefings
Stay Connected
